Furthermore, treatment of ALL cell lines with AICAR led to the phosphorylation of Akt and activation of the PI3K/Akt/mTOR pathway, and that combination of AICAR and the mTOR inhibitor rapamycin resulted in increased cytotoxicity compared to treatment with each agent alone. The gene discussed is MTOR; the disease is acute lymphoblastic leukemia.